|
|
|
|
|
|
|
|
|
Webinar: Establishing A Risk-Based Containment Strategy For High-Potency Micronization
|
As pharmaceutical pipelines advance increasingly potent compounds, containment is becoming critical to micronization strategy. This webinar explores a risk-based approach to high-potency micronization, from development through commercial scale. Discover how flexible containment and hard-wall isolators can work together to protect operators, maintain product quality, meet GMP expectations, and support scalable manufacturing. Explore practical strategies for smarter containment decisions at every stage. Click here to learn more.
|
|
|
|
|
|
Webinar | Abzena
|
Watch Erika Kovacs, Senior Director of Bioassay, as she discusses critical considerations for developing stage-appropriate bioassays to support complex biologics and bioconjugates on the path to IND.
|
|
|
|
|
|
Video | Adare Pharma Solutions
|
Join Dr. Srinivasan Shanmugam in this webinar to learn key strategies for selecting the right CDMO, reducing costs, accelerating timelines, and ensuring product success.
|
|
|
|
|
|
Webinar | KBI Biopharma
|
Explore how our technology platform accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
|
|
|
|
|
|
Video | West Pharmaceutical Services, Inc.
|
PFS system verification shouldn’t force a choice between diverting internal resources or investing in costly external testing. Uncover a more efficient path that reduces complexity, cost, and uncertainty in performance validation.
|
|
|
|
|
|
Video | Outsourced Pharma
|
This segment of the Outsourced Pharma Live event, “Charting A Direct Pathway From Academia To CDMOs,” explores when academic teams and emerging biotechs should begin engaging external development and manufacturing partners.
|
|
|
|
|
|
Video | Thermo Fisher Scientific
|
Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
|
